What Does a Potential Antitrust Lawsuit Against Amazon Mean for Sellers and Consumers?

 

U.S. regulators are preparing to drag Amazon through the jungle; Amazon is apparently the target of an antitrust lawsuit prepared by the U.S. Federal Trade Commission (FTC). The Wall Street Journal first reported on this potential legal action, which is anticipated to target a variety of Amazon’s business practices, however it’s still unclear what elements the lawsuit may highlight. If the FTC does file an antitrust lawsuit against Amazon, it would join other well-known antitrust cases like Microsoft’s acquisition of Activision Blizzard and Meta’s acquisition of Within.

Since the start of the Trump administration, the FTC has been looking into claims that Amazon favors its own products over those of independent vendors. The ecommerce giant has been under fire from several competition regulators around the world over the past year. Amazon has only recently resolved three significant antitrust probes in the European Union by altering its data collection practices and the criteria it uses to determine whether sellers are eligible to participate in its Prime service.

We’ve already seen Amazon’s iRobot deal face a tough FTC antitrust review. Is the FTC going to go through with this antitrust lawsuit against Amazon? If they do, is it going to alter how Amazon conduct business? And for the larger ecosystem dependent on Amazon’s services, what would it mean for customers as well as businesses selling their products on the marketplace? We reached out to Lesley Hansell, co-founder of Riverbend Consulting, for input. Lesley has two decades of experience as a small business consultant and has been an Amazon seller for almost a decade.

Lesley’s Thoughts:

“So, what happens if the Federal Trade Commission goes after Amazon? It could benefit some small companies that sell private-label products on the platform. Amazon, in the past, has copied some of their products in marketing and wouldn’t be able to do that any longer, but Amazon’s already cut back on their private label business.

Who really stands to lose, are consumers. The FTC has made noises about forcing Amazon to stop offering all the bundled products with Prime, and I think folks paying for that subscription and the marketplace would not be happy at all.”

Article written by Sonia Gossai.

Follow us on social media for the latest updates in B2B!

Image

Latest

Allow Doctors to Provide Care Without Making Patients Fight the Insurance System
December 3, 2025

Patients shouldn’t have to become their own case managers just to access a hip replacement, transplant, or any other life-changing procedure; the moment they’re pushed into a paperwork fight, the system has already shifted its burden onto the sick. In a functional healthcare model, clinicians and their teams handle the insurer negotiations behind…

Read More
Physician Advisors
The Impact of Physician Advisors on Hospital Revenue and Patient Advocacy in a Payer-First Era
December 3, 2025

Physician advisors are becoming the quiet linchpin of hospital resilience in a reimbursement environment where insurers increasingly treat care like a spreadsheet exercise. As payers tighten criteria and automate denials, the gap between clinical reality and business logic widens—and without a skilled physician advisor (and a disciplined appeals pathway), health systems risk watching…

Read More
payer denials
How Hospitals Can Defend Against Payer Denials Without Sacrificing Patient Care
December 3, 2025

Payer denials used to feel like a series of personal affronts—clinicians and administrators trading war stories in hallways, certain they were being shortchanged but lacking the proof to do more than fume. Today, that fog should be lifting: with data warehouses, smarter analytics, and years of claims history, hospitals can pinpoint which payers…

Read More
insurance denials
From Peer-to-Peers to Paper Wars: Inside the Daily Grind of Fighting Insurance Denials
December 3, 2025

Insurance denials have quietly become one of the most powerful forces shaping American healthcare, not through better outcomes but through a steady tightening of what insurers are willing to cover and when they’ll say so. The real scandal isn’t just that claims get rejected—it’s that the system rewards obstruction, pressuring hospitals to spend…

Read More